Oppenheimer names Cepheid (CPHD +2.1%) as a Top Idea stock and reiterates its Outperform rating...

|By:, SA News Editor

Oppenheimer names Cepheid (CPHD +2.1%) as a Top Idea stock and reiterates its Outperform rating on shares. Analysts with the firm call the molecular diagnostics company's technology platform "pioneering" with its ability to deliver results on tests for diseases to technicians within an hour.